Shanxi Zhendong Pharmaceutical
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is b… Read more
Shanxi Zhendong Pharmaceutical (300158) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.055x
Based on the latest financial reports, Shanxi Zhendong Pharmaceutical (300158) has a cash flow conversion efficiency ratio of -0.055x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-197.94 Million) by net assets (CN¥3.63 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanxi Zhendong Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Shanxi Zhendong Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanxi Zhendong Pharmaceutical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanxi Zhendong Pharmaceutical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Jiaxun Feihong Electrical Co Ltd
SHE:300213
|
0.032x |
|
Huayi Brothers Media Corp
SHE:300027
|
0.002x |
|
Banca Farmafactoring S.p.A.
LSE:0RON
|
0.865x |
|
Sanhe Tongfei Refrigeration Co. Ltd.
SHE:300990
|
0.029x |
|
SÜSS MicroTec SE
PINK:SESMF
|
0.019x |
|
PT Indo Tambangraya Megah Tbk
F:3IB
|
-0.015x |
|
Sunway Co Ltd
SHG:603333
|
-0.019x |
|
Kura Oncology Inc
NASDAQ:KURA
|
0.673x |
Annual Cash Flow Conversion Efficiency for Shanxi Zhendong Pharmaceutical (2007–2024)
The table below shows the annual cash flow conversion efficiency of Shanxi Zhendong Pharmaceutical from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.66 Billion | CN¥-149.82 Million | -0.041x | -10.85% |
| 2023-12-31 | CN¥5.14 Billion | CN¥-189.95 Million | -0.037x | -323.47% |
| 2022-12-31 | CN¥5.22 Billion | CN¥86.31 Million | 0.017x | -53.21% |
| 2021-12-31 | CN¥8.05 Billion | CN¥284.45 Million | 0.035x | -10.36% |
| 2020-12-31 | CN¥5.63 Billion | CN¥221.94 Million | 0.039x | +15.04% |
| 2019-12-31 | CN¥5.44 Billion | CN¥186.35 Million | 0.034x | +18.89% |
| 2018-12-31 | CN¥5.36 Billion | CN¥154.48 Million | 0.029x | +255.11% |
| 2017-12-31 | CN¥5.56 Billion | CN¥45.09 Million | 0.008x | +195.63% |
| 2016-12-31 | CN¥5.27 Billion | CN¥-44.72 Million | -0.008x | -111.34% |
| 2015-12-31 | CN¥2.03 Billion | CN¥151.84 Million | 0.075x | +101.19% |
| 2014-12-31 | CN¥1.97 Billion | CN¥73.23 Million | 0.037x | +197.00% |
| 2013-12-31 | CN¥1.96 Billion | CN¥-75.04 Million | -0.038x | -138.43% |
| 2012-12-31 | CN¥1.90 Billion | CN¥189.40 Million | 0.100x | +308.83% |
| 2011-12-31 | CN¥1.86 Billion | CN¥-88.73 Million | -0.048x | -362.53% |
| 2010-12-31 | CN¥1.78 Billion | CN¥32.40 Million | 0.018x | -84.54% |
| 2009-12-31 | CN¥359.31 Million | CN¥42.28 Million | 0.118x | -5.43% |
| 2008-12-31 | CN¥266.72 Million | CN¥33.18 Million | 0.124x | -82.94% |
| 2007-12-31 | CN¥176.42 Million | CN¥128.65 Million | 0.729x | -- |